(Q39302801)

English

Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 September 2017

Differential expression of organic cation transporter OCT-3 in oral premalignant and malignant lesions: potential implications in the antineoplastic effects of metformin (English)

1 reference

Europe PubMed Central

10 September 2017

1 reference

based on heuristic

inferred from title

author name string

Harsh Patel

1

1 reference

Europe PubMed Central

10 September 2017

Rania H Younis

2

1 reference

Europe PubMed Central

10 September 2017

Robert A Ord

3

1 reference

Europe PubMed Central

10 September 2017

John R Basile

4

1 reference

Europe PubMed Central

10 September 2017

Abraham Schneider

5

1 reference

Europe PubMed Central

10 September 2017

publication date

3 August 2012

1 reference

Europe PubMed Central

10 September 2017

Journal of Oral Pathology & Medicine

1 reference

Europe PubMed Central

10 September 2017

42

1 reference

Europe PubMed Central

10 September 2017

3

1 reference

Europe PubMed Central

10 September 2017

250-256

1 reference

Europe PubMed Central

10 September 2017

Metformin and reduced risk of cancer in diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Long-term metformin use is associated with decreased risk of breast cancer.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin prevents tobacco carcinogen--induced lung tumorigenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin and other biguanides in oncology: advancing the research agenda

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

TSC2 mediates cellular energy response to control cell growth and survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin reduces endogenous reactive oxygen species and associated DNA damage

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

AMPK signaling: a targetable tumor suppressor pathway?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Cellular systems for studying human oral squamous cell carcinomas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Inhibition of Mammalian target of rapamycin by rapamycin causes the regression of carcinogen-induced skin tumor lesions.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

A role for COX2-derived PGE2 and PGE2-receptor subtypes in head and neck squamous carcinoma cell proliferation.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Hypoxia-induced energy stress inhibits the mTOR pathway by activating an AMPK/REDD1 signaling axis in head and neck squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Efficacy and comparative effectiveness of sirolimus as an anticancer drug

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Current treatment options for metastatic head and neck cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Relevance of the OCT1 transporter to the antineoplastic effect of biguanides

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Clinical Pharmacokinetics of Metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin abolishes increased tumor (18)F-2-fluoro-2-deoxy-D-glucose uptake associated with a high energy diet

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Metformin suppresses intestinal polyp growth in ApcMin/+ mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0714.2012.01196.X

21 January 2018

Identifiers

10.1111/J.1600-0714.2012.01196.X

1 reference

Europe PubMed Central

10 September 2017

1 reference

Europe PubMed Central

10 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39302801&oldid=1819249233"